Frequently asked questions

Questions about our work.

The company, the methods, and the science. If your question is not here, contact us.

When was Biomarker Technologies created?

The company has been in business since 1993, when it was founded as Biomarker Technology by CEO and President Dr. J.M. (Mike) Moldowan. In 2012 it was incorporated as Biomarker Technologies, Inc. and moved into a new, custom-built 7,600 square foot laboratory in Rohnert Park, California, designed to meet or exceed the needs of absolute analytical precision.

Where are you located?

638 Martin Avenue, Rohnert Park, CA 94928. The 7,600 square foot laboratory runs an in-house Agilent Technologies triple-quadrupole system and an Agilent Technologies MSD for high-precision results.

What type of analyses do you perform?

We perform advanced analyses critical for understanding the complete petroleum system for basin modeling, applied to exploration, development and production. Our work lets clients:

  • Correlate any hydrocarbon sample: condensate, severely-biodegraded oil, seepage oil, source rock, and black oil.
  • Discover and identify deep sources for gas and condensate in mature basins.
  • Designate crude oil mixtures, then unravel and identify the components.
  • Estimate the liquids component of tight shale before fracking.
  • Model oil-charging history and estimate volumetric losses due to biodegradation.
  • Understand the role of asphaltenes in heavy oil and the provenance they preserve.
What do you specialize in?

We specialize in developing and applying advanced geochemical methodologies directly applicable to oil and gas exploration and reserves development. New exploration plays, reduced production costs and maximized yields all depend on innovative technology across engineering, geology, geophysics and geochemistry.

Alongside analyses, we offer consulting, interpretation, project design, research and development, short courses, training and internships.

Who is the founder?

Dr. J.M. (Mike) Moldowan. He began at Chevron in 1974, working first with the late Dr. Wolfgang Seifert and then leading the Biomarker Section until 1993. From 1993 to 2012 he was Professor (Research) at Stanford University, where he is now Professor Emeritus.

He has chaired the Division of Geochemistry of the American Chemical Society, holds more than 100 publications, and co-authored The Biomarker Guide (Cambridge University Press, 2005). In 2011 he received the Treibs Medal and became a Geochemical Fellow of the Geochemical Society and the European Association of Geochemistry.

What are diamondoids, and why do they matter?

Diamondoids are highly stable, cage-like hydrocarbon molecules that survive conditions which destroy conventional biomarkers. That stability makes them powerful tools for assessing thermal maturity, oil cracking and the mixing of petroleum from different sources. We offer quantitative diamondoid methods (QDA, QEDA) and compound specific isotope analysis of the diamondoids (CSIA-D).

What is Compound Specific Isotope Analysis (CSIA)?

CSIA measures the stable isotope ratios of individual compounds rather than a bulk sample, using gas chromatography coupled to isotope ratio mass spectrometry. It resolves correlations and source distinctions that bulk measurements miss. We run CSIA across alkanes, diamondoids, biomarkers, isoprenoids and aromatics.

How do I learn about upcoming workshops?

Contact Jaime or Shaun at 707-829-5551 to be added to our mailing list for upcoming training and events, or email [email protected].